Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Beriwal

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 13, 2020
Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial HysterectomyU K Iheagwara, J A Vargo, M M Boisen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
Gynecologic Oncology|August 8, 2018
Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapyZ D Horne, M J Dohopolski, D Pradhan, et al.
Brachytherapy|September 21, 2020
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experienceA Keller, J L Rodríguez-López, A K Patel, et al.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Gynecologic Oncology|July 29, 2020
Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution studyP M Pifer, R Bhargava, A K Patel, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 13, 2020
Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial HysterectomyU K Iheagwara, J A Vargo, M M Boisen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
Gynecologic Oncology|August 8, 2018
Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapyZ D Horne, M J Dohopolski, D Pradhan, et al.
Brachytherapy|September 21, 2020
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experienceA Keller, J L Rodríguez-López, A K Patel, et al.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Gynecologic Oncology|July 29, 2020
Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution studyP M Pifer, R Bhargava, A K Patel, et al.
Pageof 3